Valentina Guarnieri et. al., PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype.
Subscribe to Our Newsletter
You are leaving this research use-only area
You are about to access content intended for a different region. Information, regulatory status, and product availability may vary by location.
